ArticlePharmaceuticals (Basel, Switzerland)2025
Rapid On-Demand Point-of-Care Monitoring of Clozapine and Its Metabolite Norclozapine Using Miniature Mass Spectrometry.
Xiaosuo Wang, Wei Yi Lew, Yang Yang, Nan Zhang, Jiexun Bu, Zhentao Li, Michael Fitzpatrick, Paul Bonnitcha, David Sullivan, Wenpeng Zhang and 2 more
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Xiaosuo WangCardiometabolic-Medicine Laboratory, Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0003-3487-4614 Wei Yi LewCardiometabolic-Medicine Laboratory, Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.
Yang YangKey Laboratory of TCM Clinical Pharmacy, Shenzhen Bao'an Authentic TCM Therapy Hospital, Shenzhen 518100, China.ORCID 0009-0004-6035-5353 Nan ZhangPURSPEC Technology (Beijing) Ltd., Beijing 100084, China.
Zhentao LiDepartment of Pharmacy, The First Affiliated Hospital, Nanchang University, Nanchang 330006, China.
Michael FitzpatrickChemical Pathology, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.ORCID 0000-0001-5797-6854 Paul BonnitchaChemical Pathology, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.ORCID 0000-0002-7658-3383 David SullivanChemical Pathology, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.ORCID 0000-0003-3085-5627 Wenpeng ZhangState Key Laboratory of Precision Measurement Technology and Instruments, Department of Precision Instrument, Tsinghua University, Beijing 100084, China.ORCID 0000-0002-7018-930X Yu ZhengMental Health Service, Croydon Health Centre, Sydney Local Health District, Croydon, NSW 2132, Australia.
John F O'SullivanCardiometabolic-Medicine Laboratory, Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
approachableclozapine/norclozapineminiature mass spectrometrypoint-of-care testingreal-time analysisschizophreniatherapeutic drug monitoring
Identifiers
PMID41155664
PMCPMC12567311
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390